阿诺医药(纳斯达克股票代码:ANL)是一家临床阶段的全球性生物制药公司,在中美两地均设有研发及临床运营中心,通过“联合创新”和“自主研发”的模式构建起多条全球化的产品管线,其中:AN2025(buparlisib)取得 FDA的快速通道资格,其与紫杉醇联用期望可成为治疗PD-1失败后的二线复发性或转...Read more
100 - 249
N/A
adlainortye.com
N/A
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Adlai Nortye
Are you looking for the decision-makers at Adlai Nortye? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Adlai Nortye’s employee details in less than 30 secs.
Sign-up for 6sense Revenue AI™ for Sales
To find emails, direct dials, and more for prospects across the web.
Sign Up TodayDiscover Adlai Nortye alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.
Ivington CofE Primary School
100 - 249
Leominster
ivington.hereford.sch.uk
N/A
N/A
Hangzhou Jiang Technology Co., Ltd.
20 - 49
Hangzhou
jiangtechnology.com
Sole Proprietorship
N/A
FCCS
100 - 249
Greenwood Village
fccsconsulting.com
Private
N/A
Stanton Park Capital
0 - 9
Boston
stantonparkllc.com
Partnership
N/A
Parallax Capital Partners
100 - 249
Laguna Hills
parallaxcap.com
Private
N/A
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Adlai Nortye latest news, alerts and updates.
Adlai Nortye Ltd. Announces Closing of Initial Public Offering
Forward-Looking and Cautionary Statements This press release contains statements that constitute ‚ forward-looking statements,‚ including with respect to the proposed initial public offering and the concurrent private placement. No assurance can be ...
3 Oct 2023
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Sept. 29, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ANL) (the ‚ Company‚Äù or ‚ Adlai Nortye‚Äù), a clinical-stage biotechnology company focused on the development of innovative cancer therapies,
29 Sep 2023
IPO Update: Adlai Nortye Readies $72 Million U.S. IPO
Adlai Nortye filed for $72M IPO for its cancer drug development with a candidate in advanced stages of trials and solid financials. Learn more on ANL stock here.
11 Aug 2023
Adlai Nortye Ltd. Begins U.S. IPO Rollout
Adlai Nortye Ltd. has filed to raise $115 million in a U.S. IPO, although the final figure may differ. Click here for my first look at ANL IPO and its prospects.
31 Jul 2023
Explore frequently asked questions about Adlai Nortye’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
What is Adlai Nortye's official website?
The official website of Adlai Nortye is adlainortye.com You can find their contact number, email address, and headquarters by clicking here.
How many employees are working at Adlai Nortye?
What industry is Adlai Nortye in?
What is Adlai Nortye's tech stack?
Where are Adlai Nortye's headquarters?